Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...

ChatGPT maker OpenAI on Thursday said it will invest in a startup focused on blocking bad actors from creating biological ...

OpenAI has announced a $15 million seed investment in Red Queen Bio, a startup focused on using AI to block the creation of ...

G3 and Pivot Bio CERT-N(TM) add application flexibility and micronutrient delivery for 2026, expanding early-season access to reliable, weatherproof nitrogen. MINNEAPOLIS, Nov. 13, 2025 /PRNewswire/ - ...

J.P. Morgan, Jefferies, Citigroup and TD Cowen are acting as joint book-running managers for the proposed offering.

Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 ...

AMBROSIA is the largest study to evaluate the impact of Medical Nutrition Therapy (MNT) on diet quality and the gut microbiome, with 546 ...

OpenAI is expanding its efforts to contain emerging risks posed by artificial intelligence, backing a new biotech spinoff ...

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The ...

Investigators from the University of Science and Technology of China and RNAlfa Biotech have described a novel mRNA-based vaccine candidate against Dabie Banda virus (DBV), which has fatality rates of ...